• We were awarded the national “Specialized, Refined, and New ‘Little Giant’” (国家级专精特新“小巨人”企业) enterprise title
• Jiangsu Sinotau Pharmaceutical obtained the Radiopharmaceutical Business License (放射性药品经营许可证)
• We completed the Nov-2024 Capital Increase and the Dec-2024 Capital increase and raised approximately RMB600 million in aggregate